Lara Smith-Weber
President bij CONSTELLATION PHARMACEUTICALS, INC.
Profiel
Lara Smith-Weber is currently the President, Secretary & Treasurer at Constellation Pharmaceuticals, Inc. She previously worked as Senior VP-Controlling & Internal Controlling at MorphoSys AG, Head-Financial Planning & Analysis at MorphoSys US, Inc., and Chief Financial Officer at Onward Medical NV.
Ms. Smith-Weber received her undergraduate and graduate degrees from Stanford University and an MBA from the International Institute for Management Development.
Actieve functies van Lara Smith-Weber
| Bedrijven | Functie | Begin |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | President | 15-07-2021 |
Eerdere bekende functies van Lara Smith-Weber
| Bedrijven | Functie | Einde |
|---|---|---|
| ONWARD MEDICAL N.V. | Director of Finance/CFO | 01-10-2023 |
| MorphoSys US, Inc. | Corporate Officer/Principal | - |
| MORPHOSYS AG | Comptroller/Controller/Auditor | - |
Opleiding van Lara Smith-Weber
| Stanford University | Graduate Degree |
| International Institute for Management Development | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MORPHOSYS AG | Health Technology |
| ONWARD MEDICAL N.V. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MorphoSys US, Inc. |
